Omeros Corporation
Compositions for inhibiting MASP-2 dependent complement activation
Last updated:
Abstract:
The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation.
Status:
Grant
Type:
Utility
Filling date:
13 Jul 2018
Issue date:
16 Jun 2020